Thank you to the hundreds of people who joined us on May 20 for our online event. You can now watch a video of the event here:
Meet our panelists:
Jennifer Radin is an epidemiologist with the Digital Medicine Division at Scripps Research Translational Institute, where she conducts research to improve disease prediction and prevention by incorporating digital devices, sensors, and platforms. She is currently the PI on the Healthy Pregnancy Study, a ResearchKit app created in collaboration with WebMD, which collects online survey and sensor-related data. The study aims to better understand physiological and behavioral factors that influence a healthy pregnancy, identify complications earlier, and provide more individualized recommendations that reflect the diversity of all pregnant women. Before joining the Translational Institute, she worked with the Operational Infectious Disease Department at the Naval Health Research Center and the Influenza Division at the Centers for Disease Control and Prevention. Jennifer received her doctoral degree in Epidemiology from the University of California, San Diego and San Diego State University. She also holds a master’s of public health, specializing in Epidemiology of Microbial Diseases, from Yale University and a bachelor’s degree in Biology from the College of William and Mary.
Inder Singh is the founder and CEO of Kinsa, a public health company with a mission to stop the spread of illness through early detection and early response. Prior to founding Kinsa, Inder Singh served as the Executive Vice President of the Clinton Health Access Initiative. In this capacity, Inder worked with or advised the US’ President’s Malaria Initiative (PMI) and PEPFAR programs, the UK’s DFID, the Gates Foundation, and WHO’s UNITAID program. He brokered a series of agreements between 70 developing countries and 20 pharmaceutical companies that lowered the price of medicines for AIDS, malaria and TB, enabling millions of children to access treatment and resulted in nearly $1 billion in cost savings. Inder started his career as a software engineer and consultant. He holds 3 graduate degrees from Harvard and MIT and is a proud University of Michigan alum.
Dena Mendelsohn serves as the Director of Health Policy and Data Governance at Elektra Labs. She leads Elektra Lab’s efforts to ensure that people have improved tools to evaluate whether patient signal tracking technologies are worthy of the trust the healthcare system places in them. The advantages of connected health technologies do not have to come at the expense of privacy. Yet that is often the false choice forced on users. Ms. Mendelsohn has been at the forefront of this movement, outlining these trade-offs and highlighting them particularly to those less informed about systemic shifts. She previously served as Senior Policy Counsel at Consumer Reports, focusing on health and privacy portfolios. Ms. Mendelsohn’s advocacy around how consumers’ data is collected and used created shifts in both public discourse and policy. Before that, she was a Health Policy Analyst at the Pacific Business Group on Health. Ms. Mendelsohn earned her J.D. from Washington University in St. Louis and her Master of Public Health, health policy concentration, with great distinction from Saint Louis University.